Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.

Sanders, Jan-Stephan FMesschendorp, A Liannede Vries, Rory DBaan, Carla Cvan Baarle, Debbievan Binnendijk, RobDiavatopoulos, Dimitri AGeers, DarylSchmitz, Katharina SGeurtsvanKessel, Corine Hden Hartog, GercoKho, Marcia M LKoopmans, Marion P Gvan der Molen, Renate GRemmerswaal, Ester B MRots, NynkeGansevoort, Ron TBemelman, Frederike JHilbrands, Luuk BReinders, Marlies E J2023-02-142023-02-142023-02-143579653610.1093/cid/ciac557http://hdl.handle.net/10029/626447en© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.COVID-19chronic kidney diseasedialysiskidney transplantationmRNA-1273 vaccineAntibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.Article1537-6591Clin Infect Dis 2023;76(3):e188-e199